Printer Friendly
The Free Library
21,446,310 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Rheumatoid arthritis topic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Musculoskeletal Network Features New Research into the Cause of Rheumatoid Arthritis and Lupus. Mar 25, 2013 630
Though Over One-Third of Rheumatologists Have Prescribed Xeljanz for Their Rheumatoid Arthritis Patients, Physicians are Still Concerned With the Drug's Limited Post-Marketing Experience and Risks of Infection and Malignancy. Mar 25, 2013 701
Diversified Pipeline and Low Threat of Biosimilar Sales Erosion To Drive Growth Of Monoclonal Antibodies Market. Mar 19, 2013 1085
Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion. Mar 4, 2013 2652
Research and Markets: Orencia (Rheumatoid Arthritis) Forecast and Market Analysis 2012-2022: A Very Dynamic Market Following FDA Approval of Pfizer's Xeljanz. Jan 30, 2013 427
Research and Markets: Rituxan (Rheumatoid Arthritis) Forecast and Market Analysis 2012-2022. Jan 30, 2013 393
Important development in diagnosis of Rheumatoid Arthritis. Jan 29, 2013 775
Important development in diagnosis of Rheumatoid Arthritis. Jan 29, 2013 783
Research and Markets: PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis Event-Driven Update. Jan 29, 2013 443
Proof of Concept Study Initial Findings. Jan 28, 2013 609
Proof of Concept Study Initial Findings. Jan 28, 2013 644
New drug target for rheumatoid arthritis identified. Jan 26, 2013 670
Lipophilic stinging nettle extracts possess potent anti-inflammatory activity, are not cytotoxic and may be superior to traditional tinctures for treating inflammatory disorders. Johnsona, Tyler A.; Sohna, Johann; Inman, Wayne D.; Bjeldanesa, Leonard F.; Rayburn, Keith Report Jan 15, 2013 3598
HUNT FOR GIRLS WHO CAN'T CRY. Jan 14, 2013 361
PharmaPoint: Rheumatoid Arthritis - United Kingdom Drug Forecast and Market Analysis Event-Driven Update. Jan 8, 2013 1879
Research and Markets: Pfizer's tofacitinib - JAK inhibition -a new rheumatoid arthritis therapy paradigm. Jan 7, 2013 256
President Barack Obama Bestows NYU Langone Medical Center's Jan Vilcek, MD, PhD, with the National Medal of Technology And Innovation. Company overview Jan 7, 2013 996
QIAGEN Adds to Pipeline of Personalized Healthcare Diagnostics Through Agreements for Promising New Biomarkers. Jan 7, 2013 1942
Safeguard Scientifics Co-Leads $28M Series D for Crescendo Bioscience. Jan 3, 2013 1101
Leading Dermatologist Michael P. Heffernan, M.D. and Renowned Rheumatologist Alisa E. Koch, M.D. Join Lilly Autoimmune Team. Jan 3, 2013 1285
Cauliflower the head of the cruciferous vegetable family. Gamonski, William Report Jan 1, 2013 1820
Belgium,Japan : Astellas and UCB announce approval of Cimzia (certolizumab pegol) in Japan for the treatment of adult patients with rheumatoid arthritis. Dec 26, 2012 446
Mayo Clinic Health Letter, December 2012 Highlights: Reducing the Risk of Disability from Rheumatoid Arthritis; Basic Remedies for Tongue Problems; Causes of Swollen Legs. Dec 19, 2012 1377
Although Orencia SC Enjoys a High Trial and Usage Rate One Year Post-Launch in Rheumatoid Arthritis, It Remains a Second-Line Therapy after TNF Inhibitors According to a Recent BioTrends Report. Dec 17, 2012 542
Antares Pharma Announces Submission of New Drug Application for OTREXUP[TM]. Dec 17, 2012 1377
In the U.S., Approximately 80 Percent of Current Prescribers of Remicade and/or Rituxan Indicate They Would Prescribe Biosimilar Versions of These Agents Within a Year of Their Approval for Rheumatoid Arthritis. Dec 17, 2012 655
AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis. Dec 13, 2012 1463
Lilly Discontinues One of Three Phase 3 Rheumatoid Arthritis Registration Studies for Tabalumab. Dec 13, 2012 949
LILLY (ELI) & COMPANY - Tabalumab RA Study BCDM Discontinuation. Dec 13, 2012 963
UCB, Inc. and Arthritis Foundation Partner to Celebrate the "Everyday Victories" of the Rheumatoid Arthritis Community. Dec 11, 2012 1268
Biologic Agents are Being Used Earlier and More Often to Treat Rheumatoid Arthritis in the EU5, According to Two Recent Reports from BioTrends. Dec 6, 2012 635
By Year-End 2015, Surveyed European Rheumatologists Anticipate That the Launches of Biosimilar Etanercept and Infliximab Will Sustain Total Patient Shares of These Molecules at the Expense of Humira in the Rheumatoid Arthritis Drug Market. Dec 5, 2012 740
Study Finds High-dose Intravenous Vitamin C Reduces Pain and Inflammation in Those with Rheumatoid Arthritis as Reported in a Recent Paper Published by Riordan Clinic Scientists. Dec 5, 2012 659
New rheumatoid arthritis drug targets NIH-discovered protein. Brief article Dec 4, 2012 131
Risk of rheumatoid arthritis with elevated rheumatoid factor. Dec 1, 2012 410
Flake-shaped rice bodies. Kichari, J.R.; Bezooijen, R. Clinical report Dec 1, 2012 604
The low prevalence of rheumatoid arthritis in two regions of Serbia based on evidence-based data / Kanita dayali verilere gore sirbistan'in iki bolgesinde romatoid artritin dusuk prevalansi. Stojanovic, Roksanda; Jovicevic, Radmila; Glogovac, Branka; Radosavljevic, Natasa; Svenda, Mirjana Z Clinical report Dec 1, 2012 3106
A possible relationship between polymorphisms of glutathione S-transferase M1, P1 and T1 genes and rheumatoid arthritis in Zahedan, Southeast Iran / Guneydogu Iran Zahedan'da glutation S-transferaz M1, P1 ve T1 genlerinin polimorfizmlerive romatoid artrit arasindaki muhtemel iliski. Hashemi, Mohammad; Eskandari-Nasab, Ebrahim; Zakeri, Zahra; Atabaki, Mahdi; Rezaei, Hamzeh; Bahari, Report Dec 1, 2012 2472
Protalex, Inc. Announces Dosing Of First Patient In U.S. For New Trial Of PRTX-100 In Patients With Active Rheumatoid Arthritis. Clinical report Nov 29, 2012 688
'Walking on marbles' to soon become thing of past for arthritis patients. Nov 28, 2012 473
Tofacitinib approved for rheumatoid arthritis. Mechcatie, Elizabeth Nov 15, 2012 550
Incyte Achieves $50 Million Milestone as Oral JAK1/JAK2 Inhibitor Baricitinib Advances into Phase III Development for Rheumatoid Arthritis. Nov 15, 2012 427
Blood marker can help diagnose Rheumatoid Arthritis; New data at the 2012 Annual Meeting of the American College of Rheumatology. Nov 14, 2012 628
Antares Pharma Announces Positive Results from Final MTX Medi-Jet[TM] Clinical Study. Clinical report Nov 13, 2012 1078
RAPID(TM)-axSpA study showed certolizumab pegol reduced signs and symptoms of axial spondyloarthritis. Nov 13, 2012 5763
UCB Announces Data on Cimzia (certolizumab pegol) for Patients with Moderate to Severe Rheumatoid Arthritis at American College of Rheumatology 2012 Congress. Clinical report Nov 13, 2012 4570
Amgen and Pfizer Highlight Data to be Presented at American College of Rheumatology Meeting. Nov 12, 2012 3020
Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis. Nov 12, 2012 2994
New Head-to-Head Patient Reported Outcomes Data for Orencia [R] SC (abatacept) vs. Humira[R] (adalimumab) Presented at the 2012 American College of Rheumatology Annual Scientific Meeting. Nov 12, 2012 1991
Infinity Reports Phase 1 Data for IPI-145 at ACR/ARHP Supporting Development in Inflammatory Conditions. Nov 12, 2012 1339
SetPoint Medical Presents Positive Clinical Results for First Human Study of Implantable Neuromodulation Device for Rheumatoid Arthritis. Clinical report Nov 12, 2012 640
Abbott Announces Results of Analysis Exploring the Use of HUMIRA (Adalimumab) in Simultaneously Achieving Three Key Treatment Goals for Rheumatoid Arthritis. Financial report Nov 12, 2012 1840
Abbott Announces Results of Analysis Exploring the Use of HUMIRA (Adalimumab) in Simultaneously Achieving Three Key Treatment Goals for Rheumatoid Arthritis. Financial report Nov 12, 2012 1847
ADACTA Study Showed ACTEMRA Improved Signs and Symptoms of Rheumatoid Arthritis Significantly More Than Adalimumab as a Single-Agent Therapy. Nov 10, 2012 1534
Research and Markets: Global Rheumatoid Arthritis Drug Pipeline Capsule - 2012 Update Provides Information on Pipeline Molecules Developed In Leading Geographies. Nov 9, 2012 305
MULTIMEDIA: U.S. Food And Drug Administration Approves Pfizer's XELJANZ[R] (tofacitinib citrate) for Adults with Moderately to Severely Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response or Intolerance to Methotrexate. Nov 8, 2012 2230
Protalex, Inc. Announces Screening Of First Patients In U.S. For New Trial Of PRTX-100 In Patients With Active Rheumatoid Arthritis. Clinical report Nov 8, 2012 686
Research and Markets: Global Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2012. Clinical report Nov 1, 2012 264
Legionella pneumophila serotype 1 pneumonia in patient receiving adalimumab. Wuerz, Terry C.; Mooney, Owen; Keynan, Yoav Nov 1, 2012 1662
United Kingdom,United States : Drawbacks in Current Rheumatoid Arthritis Therapies Point to a Large Untapped Market in the U.S., Finds Frost & Sullivan. Oct 19, 2012 310
Drawbacks in Current Rheumatoid Arthritis Therapies Point to a Large Untapped Market in the U.S., Finds Frost & Sullivan. Oct 18, 2012 935
Drawbacks in Current Rheumatoid Arthritis Therapies Point to a Large Untapped Market in the U.S., Finds Frost & Sullivan. Oct 18, 2012 937
Protalex, Inc. To Present Phase 1b PRTX-100 Data At The 2012 American College of Rheumatology Annual Meeting. Oct 18, 2012 730
Switzerland : FDA Approves Expanded Indication for ACTEMRAA in Rheumatoid Arthritis. Oct 16, 2012 441
Cell Therapeutics' Unique Orally Available, Multi-Kinase (JAK2, FLT3, c-Fms) Inhibitor CT-1578 Demonstrates Ability to Prevent the Onset of Rheumatoid Arthritis and Potency in Treating and Reversing Bone and Cartilage Damage In Preclinical Models. Oct 15, 2012 1224
Arthritis stats and figures. Oct 14, 2012 336
Arthritis patient was diagnosed at just 12 months. Oct 14, 2012 509
Research and Markets: Rheumatoid Arthritis - Pipeline Review, H2 2012. Oct 12, 2012 363
CreakyJoints Announces "Reward Your RA Success". Oct 12, 2012 658
Be aware of arthritis signs. Oct 12, 2012 302
Augurex Announces Exclusive License Agreement with Quest Diagnostics for the Development of Arthritis Biomarker 14-3-3? as a Testing Service in the U.S. Oct 9, 2012 559
Research and Markets: Key Findings from Treatment Algorithms: Rheumatoid Arthritis - Disease-Modifying Agents. Oct 8, 2012 293
'Humanized' mice may enable discovery of better medicines for rheumatoid arthritis. Oct 5, 2012 572
Subcutaneous Formulation of ORENCIA (abatacept) Approved by European Commission. Oct 5, 2012 2095
Rheumatologists Continue to Prefer Enbrel and Humira as Both Their First and Second Line Biologic Agents and the Combined Formulations of Orencia as the Dominant Third Line Agent, According to a Recent BioTrends Report. Oct 4, 2012 651
Research and Markets: What are European Physician and Payer Expectations for the Uptake of Emerging Oral Immunomodulators in Rheumatoid Arthritis? Oct 3, 2012 305
United States : Janssen Announces Worldwide Agreement To Develop And Commercialize JAK Inhibitor For Immunological Diseases. Oct 3, 2012 423
Janssen Announces Worldwide Agreement To Develop And Commercialize JAK Inhibitor For Immunological Diseases. Oct 1, 2012 828
Research and Markets: Rheumatoid Arthritis (Event Driven). Sep 27, 2012 312
Antares Pharma Announces Successful Results from VIBEX MTX Actual Human Use Study. Clinical report Sep 25, 2012 1308
Although Biologic Therapy Continues to be Effective for Rheumatoid Arthritis Patients, Tofacitinib May Alter the Treatment Paradigm. Sep 24, 2012 638
Janssen Submits Application To FDA Requesting Approval Of SIMPONI Intravenous Formulation For Treatment Of Moderately To Severely Active Rheumatoid Arthritis. Sep 18, 2012 2753
Pfizer Announces Data For Investigational Compound Tofacitinib In Rheumatoid Arthritis To Be Presented At The American College Of Rheumatology 2012 Annual Meeting. Sep 17, 2012 2216
The Rheumatoid Arthritis Drug Market Will Experience Modest Growth as Sales Increase from $11.1 Billion in 2011 to $15.2 Billion in 2021. Sep 13, 2012 622
Japan : Eisai announces launch of anti-rheumatic agent careram. Sep 12, 2012 385
Japan : Anti-Rheumatic Agent Careram(R) established by Eisai. Sep 12, 2012 372
The United States Rheumatic Diseases Therapeutics Market. Sep 11, 2012 350
Eisai Announces Launch of Anti-Rheumatic Agent Careram(R). Sep 11, 2012 534
Zalicus Reports Top Line Phase 2b Trial Results with Synavive in Rheumatoid Arthritis. Sep 10, 2012 845
'Nobody had actually said to me that I was about to spend the rest of my life in a wheelchair, but it was becoming obvious'. Sep 10, 2012 371
Research and Markets: The United States Rheumatic Diseases Therapeutics Market: Changes on the Horizon with Novel Oral Therapies for Musculoskeletal Indications. Sep 7, 2012 445
Raised antibody levels in blood linked to greater risk of rheumatoid arthritis. Sep 7, 2012 431
United Kingdom : GSK launches dosing in Phase III rheumatoid arthritis program jointly with JANSSEN. Clinical report Sep 7, 2012 347
Cardiovascular events halved in anti-TNF users with RA. Zoler, Mitchel L. Sep 1, 2012 672
From pathology to diagnosis: a symptom-free patient with a rheumatoid nodule in the foot / patolojiden taniya: semptomsuz bir hastada ayakta romatoid nodul. Tastekin, Ebru; Btrtane, Murat; Kilinc, Serdar; Ciftdemtr, Mert; Usta, Ufuk; Tastekin, Nurettin Report Sep 1, 2012 2250
Posterior interosseous nerve entrapment in a patient with rheumatoid arthritis / Romatoid artritli bir hastada posterior interosseoz sinir tuzaklanmasi. Baklaci, Korhan; Ozgul, Ahmet Sep 1, 2012 2345
Surveyed Rheumatoid Arthritis Patients on Biologic Therapy Believe That the Benefits Outweigh the Risks for Available Biologics, with Enbrel Rating the Highest, According to a Recent BioTrends Report. Aug 30, 2012 557
Protalex, Inc. Completes Analysis of Data from Phase 1b Dose Escalation Study of PRTX-100 in Patients with Active Rheumatoid Arthritis. Aug 29, 2012 1039
Ireland : PHASE 3 PROGRAM of SIRUKUMAB started by JANSSEN BIOLOGICS. Aug 27, 2012 315
Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis. Aug 23, 2012 586
Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis. Aug 23, 2012 578
U.S. Food And Drug Administration Extends Action Date For Tofacitinib New Drug Application By Three Months. Aug 21, 2012 1184
Abbott Japan and Eisai Receive Approval to Market the Fully Human Anti-TNF-Alpha Monoclonal Antibody Humira(R). Aug 10, 2012 661
New 'smart' drug uses patients' own body to beat arthritis. Aug 9, 2012 362
Safely manage joint inflammation: curcumin. Evans, Susan Report Aug 1, 2012 5087
A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Brief article Aug 1, 2012 200
Curcumin protects human chondrocytes from IL-I1beta-induced inhibition of collagen type II and beta1-integrin expression and activation of caspase-3: an immunomorphological study. Aug 1, 2012 262
Early data find no adalimumab teratogenicity. MeChcatie, Elizabeth Clinical report Aug 1, 2012 585
Biomarkers and genes predictive of disease predisposition and prognosis in rheumatoid arthritis: rheumatoid arthritis is a debilitating disease which often progresses to relentlessly severe disease. Meyer, Pieter W.A. Aug 1, 2012 3133
Septic arthritis due to Kingella kingae in an adult patient. Sanghvi, Ajay; Addidle, Michael; Grimwade, Kate Case study Aug 1, 2012 1905
Pfizer Announces Positive Top-Line Results From The ORAL Start Phase 3 Study Of Tofacitinib In Rheumatoid Arthritis. Jul 31, 2012 1122
Abbott's HUMIRA (adalimumab) Approved in Europe for Treatment of Non-radiographic Axial Spondyloarthritis (nr-axSpA). Jul 30, 2012 1196
BioTrends Research Group Has Published Its First Ever Report on Rheumatoid Arthritis from Patients' Perspectives in the UK, Germany, Italy and Spain. Jul 30, 2012 629
Genentech Reports Second Positive Study of ACTEMRA[R] Given by Subcutaneous Injection to Patients with Rheumatoid Arthritis. Jul 27, 2012 1314
Protalex, Inc. Findings from Phase 1b Dose Escalation Study of PRTX-100 in Patients with Active Rheumatoid Arthritis. Jul 26, 2012 699
Pharmspective Releases New Pipeline Perspectives Reports in Key Autoimmune Diseases. Jul 25, 2012 847
Moderate drinking lowers risk of rheumatoid arthritis in women. Jul 18, 2012 514
Research and Markets: United States Market for Rheumatoid Arthritis Pharmacotherapeutics. Jul 16, 2012 234
Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance. Lu, Yue; Xiao, Juan; Wu, Zai-Wang; Wang, Zhe-Ming; Hu, Jia; Fu, Hong-Zheng; Chen, Ying-Yu; Qian, Rui Report Jul 15, 2012 5714
Stricken golf star gets a 'miracle' second chance. Jul 12, 2012 602
3 drinks per week reduces risk of developing arthritis by 50pc. Jul 11, 2012 514
Research and Markets: United States Market for Ankylosing Spondylitis Pharmacotherapy. Jul 11, 2012 538
Enbrel and Humira Continue to Be Used as the Preferred First and Second Line Biologic Agents to Treat Rheumatoid Arthritis, but Orencia SC's Usage Has Increased over the Last Six Months. Jul 10, 2012 649
Research and Markets: Ankylosing Spondylitis (Bekhterev's Disease) Global Clinical Trials Review, H1, 2012. Jul 3, 2012 369
Rheumatoid arthritis can lead to unemployment and early death. Jul 2, 2012 516
Chelsea Therapeutics Reports on Phase II CH-4051 For Arthritis. Clinical report Jul 1, 2012 484
ChemoCentryx Reports Positive Phase 2 Data with CCX354,. Jul 1, 2012 861
Halt the auto-immune attack of arthritis. Downey, Michael Report Jul 1, 2012 4826
The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. Jul 1, 2012 433
Effects of oral administration of type II collagen on rheumatoid arthritis. Brief article Jul 1, 2012 135
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Author abstract Jul 1, 2012 332
Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration. Jul 1, 2012 352
A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis. Author abstract Jul 1, 2012 408
Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis. Jul 1, 2012 337
New rheumatoid arthritis definition hangs on three joints. Zoler, Mitchel L. Disease/Disorder overview Jul 1, 2012 536
Concentration of Nitric Oxide in saliva of patients with rheumatoid arthritis. Dervisevic, Amela; Babic, Nermina; Huskic, Jasminko; Sokolovic, Sekib; Nakas-Icindic, Emina; Causevi Report Jul 1, 2012 3417
MDHAQ/RAPID3 can provide a roadmap or agenda for all rheumatology visits when the entire MDHAQ is completed at all patient visits and reviewed by the doctor before the encounter. Pincus, Theodore; Skummer, Philip T.; Grisanti, Michael T.; Castrejon, Isabel; Yazici, Yusuf Jul 1, 2012 5070
Predictors of response to TNF inhibitors in rheumatoid arthritis: do we have new tools for personalized medicine? Simsek, Ismail Jul 1, 2012 2842
T-cell agents in the treatment of rheumatoid arthritis: 2012 update. Solomon, Gary E. Jul 1, 2012 2643
IL-6 inhibition for the treatment of rheumatoid arthritis and other conditions. Woodrick, Robert S.; Ruderman, Eric M. Jul 1, 2012 3587
B-cell therapies for rheumatoid arthritis. Scher, Jose U. Jul 1, 2012 2975
Kinase inhibitors for the treatment of rheumatoid arthritis. Yazici, Yusuf; Steiger, Benjamin Jul 1, 2012 3497
Heavy snorers at 'double risk' of rheumatoid arthritis. Jun 29, 2012 528
Eisai and Toyama Chemical Receive Approval to Market Anti-rheumatic Agent Iguratimod in Japan. Jun 29, 2012 470
Research and Markets: Sjogren's Syndrome Global Clinical Trials Review, H1, 2012. Jun 28, 2012 351
Programme launched for early detection of rheumatoid arthritis. Jun 28, 2012 409
Infinity Reports Preclinical Data for IPI-145 and Announces Initial Indications for Phase 2 Development in Inflammation. Jun 27, 2012 1433
Antares Pharma Announces Positive Results from VIBEX MTX Usability Study. Report Jun 26, 2012 703
Study Validates Use of Crescendo Bioscience's Vectra[TM] DA Test as an Objective Measure of Rheumatoid Arthritis Disease Activity. Jun 26, 2012 1076
Abbott Receives Positive Opinion for HUMIRA in Non-radiographic Axial Spondyloarthritis from EMA's CHMP. Jun 25, 2012 1079
New arthritis programme sees ME launch. Jun 24, 2012 630
Research and Markets: The Rheumatoid Arthritis Community is Swelling with Anticipation as its Research Pipeline Begins to Burst. Jun 22, 2012 352
The Use of Biologics for Rheumatoid Arthritis in China is Limited to the Biosimilar Yi Sai Pu and Branded Etanercept, According to a Recent BioTrends Report. Jun 21, 2012 577
Questcor Announces Initial Commercialization Plans for Acthar Rheumatology Indications. Jun 14, 2012 1866
Illness hits patients and their families; Grant may help arthritis sufferers and loved ones. Jun 13, 2012 608
Changes in gut bacteria may trigger diseases like rheumatoid arthritis. Jun 12, 2012 675
Research centre gives hope to arthritis patients. Jun 11, 2012 340
ARTHRITIS TRIAL HOPE. Jun 9, 2012 242
HOPE ON ARTHRITIS; New treatment hailed the best at relieving symptoms. Jun 8, 2012 229
Arthritis sufferers in new treatment hope; Drug trialled on Tyneside 'more likely to halt progression'. Jun 8, 2012 409
Post Hoc Analysis Indicated That Timing And Magnitude Of Initial Response To Certolizumab Pegol Predicted Likelihood Of Low Disease Activity At Week 28 In Patients With Active Moderate To Severe Rheumatoid Arthritis. Clinical report Jun 8, 2012 3987
Research and Markets: Sjogren's Syndrome - Pipeline Review, H1 2012. Jun 7, 2012 455
ORENCIA[R] (abatacept) Demonstrates Comparable Efficacy to Humira[R] (adalimumab) in Patients with Moderate to Severe Rheumatoid Arthritis in First Head-to-Head Study of These Agents. Jun 6, 2012 2218
Arthritis treatment 'too little, too late' Patients are 'left until they are disabled'. Jun 6, 2012 461
Abbott Presents Phase 3 Study Results for Investigational Use of HUMIRA (Adalimumab) in Patients with Active Peripheral Spondyloarthritis. Clinical report Jun 6, 2012 1440
RAPID(TM)-PsA study showed that certolizumab pegol improved the signs and symptoms of psoriatic arthritis. Jun 6, 2012 3724
Abbott Announces 10-Year Data Evaluating HUMIRA (Adalimumab) for Patients with Long-Standing Moderate-to-Severe Rheumatoid Arthritis. Clinical report Jun 6, 2012 1807
ORENCIA ,u- (abatacept) Demonstrates Comparable Efficacy to Humira (adalimumab) in Patients with Moderate to Severe Rheumatoid Arthritis in First Head-to-Head Study of These Agents. Jun 6, 2012 2042
Abbott Announces 10-Year Data Evaluating HUMIRA (Adalimumab) for Patients with Long-Standing Moderate-to-Severe Rheumatoid Arthritis. Clinical report Jun 6, 2012 1809
New Phase 3 Data Show SIMPONI Intravenous Formulation Significantly Improved Rheumatoid Arthritis Signs And Symptoms In Patients With Active Disease. Jun 5, 2012 3096
Crescendo Bioscience's Vectra[TM] DA Test Indicates Remission in Rheumatoid Arthritis Patients. Jun 5, 2012 2024
Genentech's ACTEMRA[R] Improved Rheumatoid Arthritis Signs and Symptoms Significantly More Than Adalimumab as Single-Agent Therapy. Jun 5, 2012 1582
UCB to showcase broad immunology portfolio at EULAR 2012. Jun 1, 2012 4434
BCM-95 curcumin as effective as prescription drug in rheumatoid arthritis. Clinical report Jun 1, 2012 194
Follow-up results of our patients with rheumatoid arthritis / romatoid artritli hastalarimizin takip sonuclari. Yalcin, Tugba; Bal, Ajda; Dulgeroglu, Deniz; Cakci, Aytul Report Jun 1, 2012 6263
Validation of the Personal Impact Health Assessment Questionnaire in patients with rheumatoid arthritis in Kerman, Iran / Iran Kerman'da romatoid artrit hastalarinda Kisisel Saglik Degerlendirme Anketi'nin dogrulanmasi. Shakibi, Mohammad Reza; Zolala, Farzaneh; Monshi, Mahdookht; Hghdoost, Ali Akbar Survey Jun 1, 2012 3710
A lytic lesion on the head of the fifth metatarsal bone mimicking rheumatoid arthritis in a geriatric patient / geriatrik bir olguda besinci metatars basinda romatoid artriti taklit eden litik lezyon. Isik, Metin Jun 1, 2012 497
Surveyed U.S. Rheumatologists and MCO Pharmacy Directors Agree That a Drug's Effect on the Signs and Symptoms of Rheumatoid Arthritis is One of the Attributes That Most Influences Their Decisions Regarding Prescribing and Formulary Status. May 31, 2012 624
Six Months Post-Launch, Trial and Usage of Orencia SC is Continuing to Increase, Yet It is Still Viewed as a Second-Line Therapy After Anti-TNF Agents for Rheumatoid Arthritis Based on a Recent BioTrends Report. May 30, 2012 695
Abbott to Present Wide Range of Investigational Efficacy, Safety and Health Outcomes Data on HUMIRA (Adalimumab) at the Annual Meeting of the European League Against Rheumatism. May 29, 2012 1882
VQ OrthoCare[R] Announces New Treatment Option for Rheumatoid Arthritis. May 24, 2012 541
New target to battle rheumatoid arthritis identified. May 21, 2012 589
Research and Markets: Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2012. Report May 16, 2012 461
Panel recommends tofacitinib approval for refractory RA. Tucker, Miriam E. May 15, 2012 708
Bristol-Myers Squibb to Present New Data on ORENCIA(R),u- (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress. Clinical report May 14, 2012 1217
FDA Arthritis Advisory Committee Recommends Approval of Tofacitinib for Adult Patients with Moderately to Severely Active Rheumatoid Arthritis. May 9, 2012 863
Genentech Reports Positive Study of ACTEMRA Given by Subcutaneous Injection. May 3, 2012 1010
Anemia triples infection risk with biologics. London, Susan May 1, 2012 601
Zalicus Completes Patient Enrollment in Phase 2b Clinical Trial of Synavive in Rheumatoid Arthritis. Apr 30, 2012 901
Research and Markets: Global Rheumatoid Arthritis Drugs Market 2011-2015 - The Global Rheumatoid Arthritis Drugs Market to Grow At A CAGR Of 12.1 Percent over the Period 2011-2015. Apr 13, 2012 366
New classification criteria released for research on Sjogren's Syndrome. Apr 11, 2012 118
My hands are gnarly and painful, but I won't let arthritis take over; FIVE PAGES OF HEALTH, BEAUTY AND LIFESTYLE SCOTS TELLY STAR AGGIE MACKENZIE IS DETERMINED ILL HEALTH WILL NOT WIN. Apr 3, 2012 938
RA autoimmunity may smolder in the lungs. Jancin, Bruce Apr 1, 2012 569
Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastic therapy. Alias, Abie; Rodriguez, Ernesto J.; Bateman, Helen E.; Sterrett, Ashley G.; Valeriano-Marcet, Joanne Disease/Disorder overview Apr 1, 2012 4110
An evidence-based medical visit for patients with rheumatoid arthritis based on standard, quantitative scientific data from a patient MDHAQ and physician report. Pincus, Theodore; Castrejon, Isabel Report Apr 1, 2012 9164
Endosymbiotic actinidic archaea and viroids-role in immune regulation. Ravikumar, Kurup A.; Kurup, Parameswara Achutha Report Mar 31, 2012 3288
Research and Markets: Disease Modification in Rheumatoid Arthritis - Game-changing Therapy Close to Market. Mar 29, 2012 519
Rheumatologists Continue to Increase Their Use of Biologics for the Treatment of RA Compared to a Year Ago, but Areas of Improvement Exist for This Drug Class. Mar 28, 2012 544
Research and Markets: Rheumatoid Arthritis - Pipeline Review, H1 2012. Mar 27, 2012 432
Atrial fibrillation, stroke risks elevated in RA. Splete, Heidi Mar 15, 2012 551
Rheumatoid arthritis ups risk of irregular heart rhythm and stroke. Mar 9, 2012 341
Arthritis sufferers offered new hope; Breakthrough set to go to clinical trials. Mar 6, 2012 598
Genentech's ACTEMRA[R] Monotherapy Showed Superior Improvement in Rheumatoid Arthritis Signs and Symptoms Versus Adalimumab Monotherapy. Mar 2, 2012 1296
Sjogren's syndrome presenting with epileptic seizure/Ilk bulgusu epilepsi nobeti olan primer Sjogren sendromu. Koc, Emine Rabia; Duzgun, Ulkuhan; Ersoy, Alevtina; Ilhan, Atilla Case study Mar 1, 2012 1149
Arthritis pattern in psoriasis guides diagnosis. Jancin, Bruce Mar 1, 2012 594
Biologic users mycobacterial lung infection. Jancin, Bruce Mar 1, 2012 792
TNF inhibitors did not raise risk of zoster in large study. Jancin, Bruce Clinical report Mar 1, 2012 686
Using clinical and multislice computer tomographic features to assess temporomandibular joint osseous involvement in rheumatoid arthritis: a preliminary study / Romatid artritte osseoz temporomandibuler eklem tutulumunun klinik ve cok kesitli bilgisayarli tomografi ozellikleri: on calisma. Gheita, Tamer; Dahaba, Moushira; Ahmed, Eman; Khalifa, Shorouk; Basmy, Ayman Report Mar 1, 2012 5472
Rheumatoid arthritis: a rare cause of cardiac tamponade / Kardiyak tamponadin nadir bir nedeni: romatoid artrit. Canga, Yigit; Ozcan, Kazim Serhan; Karatas, Mehmet Baran; Durmus, Gunduz; Erdinler, Izzet Celal Report Mar 1, 2012 1488
Approval for drug after trial in North. Feb 22, 2012 253
Glucocorticoid injections controlled early RA. Worcester, Sharon Feb 15, 2012 532
Joint surgery growing less common in RA. McCall, Becky Clinical report Feb 15, 2012 514
Rheumatoid arthritis drug halts organ damage in inflammatory genetic disorder. Feb 11, 2012 598
RA, erectile dysfunction association seen. Wachter, Kerri Feb 1, 2012 236
Prior glucocorticoids raise infection risk in RA. McCall, Becky Feb 1, 2012 624
Benitec Biopharma, Medistem Technologies combine preclinical stem cell therapy for rheumatoid arthritis. Clinical report Feb 1, 2012 143
Arthritis is too painful to enjoy life; HEALTH. Jan 24, 2012 136
Corticosteroids as disease modifying drugs in rheumatoid arthritis treatment. Yazici, Yusuf Jan 15, 2012 2294
Effective initial and long-term prednisone in doses of less than 5 mg/day to treat rheumatoid arthritis: documentation using a patient self-report Multidimensional Health Assessment Questionnaire (MDHAQ). Pincus, Theodore; Castrejon, Isabel Clinical report Jan 15, 2012 5423
Short-term and long-term safety of glucocorticoids in rheumatoid arthritis. Saag, Kenneth G. Clinical report Jan 15, 2012 3757
A fresh look at glucocorticoids: how to use an old ally more effectively. Buttgereit, Frank Jan 15, 2012 2640
Circadian rhythms in disease activity, signs and symptoms, and rationale for chronotherapy with corticosteroids and other medications. Haus, Erhard; Sackett-Lundeen, Linda; Smolensky, Michael H. Report Jan 15, 2012 4399
Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical care. Pincus, Theodore; Yazici, Yusuf; Castrejon, Isabel Clinical report Jan 15, 2012 2948
Venus Williams pulls out of Australian Open over flare up of Sjogren's syndrome. Jan 10, 2012 233
RainDance Technologies Teams with Hospital Saint-Louis and BGI to Confirm Mutations Associated with Rheumatoid Arthritis. Jan 9, 2012 1016
Arthritis patients need more exercise, CDC says. Splete, Heidi Jan 1, 2012 511
Subcutaneous biologic for RA stacks up well. Schonfeld, Amy Rothman Jan 1, 2012 709
Tocilizumab monotherapy for RA may suffice for some. Schonfeld, Amy Rothman Jan 1, 2012 783
Pharmacological properties of herbal oil extracts used in Iranian traditional medicine. Mikaili, Peyman; Shayegh, Jalal; Sarahroodi, Shadi; Sharifi, Massoumeh Report Jan 1, 2012 3140
Running with Sjogren's syndrome. Handy, Beverly C.; Handy, Dexter R. Jan 1, 2012 962
A cholesterol and actinide dependent shadow biosphere of archaea and viroids in autoimmune diseases. Kurup A., Ravikumar; Kurup, Parameswara Achutha Report Dec 31, 2011 4090
Rosehips and rheumatoid arthritis. Finney-Brown, Tessa Report Dec 22, 2011 412
UCB Announces Start of the EXXELERATE(TM) Clinical Study in Rheumatoid Arthritis. Clinical report Dec 21, 2011 2968
Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis. Dec 20, 2011 712
Up to 58 Percent of Surveyed Rheumatologists in France, Germany, Italy and the United Kingdom Expect to Initially Prescribe Tofacitinib for Rheumatoid Arthritis Only to Patients with Normal Cholesterol Levels. Dec 7, 2011 524
Gold Standard Diagnostics Launches Axis-Shield's New and Improved Anti-CCP2 Assay for Early and Accurate Diagnosis of Rheumatoid Arthritis. Dec 6, 2011 475
Low-dose prednisone shores up effects of MTX-based regimens in early RA. Worcester, Sharon Dec 1, 2011 493
Trial Backs Methotrexate as first Tx for early RA. Worcester, Sharon Dec 1, 2011 555
RA doubles fracture risk in women. Wachter, Kerri Dec 1, 2011 436
Beware of those beers. Greenbaum, Larry Dec 1, 2011 1043
Editorial. Rheumatol, Turk J. Editorial Dec 1, 2011 581
Management of rheumatoid arthritis: consensus recommendations from the Turkish League Against Rheumatism / romatoid artritin tedavisi: Turkiye romatizma arastirma ve savas dernegi uzlasi onerileri. Ataman, Sebnem; Borman, Pinar; Evcik, Deniz; Aydog, Ece; Ayhan, Figen; Yildizlar, Derya; Bodur, Hati Report Dec 1, 2011 16674
Eosinophilic gastroenteritis associated with rheumatoid arthritis / eozinofilik gastroenterit ile romatoid artrit birlikteligi. Paksoy, Fatma; Ulas, Turgay; Namal, Esat; Gulturk, Emine; Aydogan, Timucin; Borlu, Fatih Clinical report Dec 1, 2011 1570
Lupus myositis with normal creatinine kinase levels following adalimumab use in a rheumatoid arthritis patient / bir romatoid artrit hastaslnda adalimumab kullanlmlnln ardlndan gelisen ve normal kreatinin kinaz seviyelerinin eslik ettigi lupus miyoziti. Almoallim, Hani; ALmasari, Ahlam; Khadawardi, Hadeel Report Dec 1, 2011 2427
Bisphosphonate-related osteonecrosis of the jaw bones in a patient with ankylosing spondylitis receiving anti-tumor necrosis factor treatment / anti-tumor nekroz faktor tedavisi alan ankilozan spondilitli bir olguda gelisen bifosfonatla iliskili cene osteonekrozu. Isleten, Banu; Hepguler, Simin; Bayraktaroglu, Selen; Keser, Gokhan Report Dec 1, 2011 2464
Pfizer Announces European Medicines Agency Acceptance Of Regulatory Submission For Tofacitinib For The Treatment Of Rheumatoid Arthritis. Nov 21, 2011 536
BioTrends Survey of Over 1,300 Patients with Autoimmune Disorders Indicates High Disease Impact on Quality of Life Metrics and Challenges Patients Face with Their Disease. Clinical report Nov 21, 2011 478
ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthritis. Nov 8, 2011 1407
New Data From REALISTIC Study Showed Cimzia (certolizumab pegol) Provided Rapid and Sustained Efficacy, Over 28 Weeks, in a Broad Population of Patients With Moderate to Severe Rheumatoid Arthritis (RA) Including Those Who Discontinued Prior Anti-TNF Therapy. Nov 7, 2011 3254
Abbott Announces New Long-Term Data Evaluating Use of HUMIRA (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA. Clinical report Nov 6, 2011 1397
Abbott Announces New Long-Term Data Evaluating Use of HUMIRA (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA. Clinical report Nov 6, 2011 1323
Young women with rheumatoid arthritis 'at greater risk of fractures'. Nov 6, 2011 325
Mayo Clinic: Young Women with Rheumatoid Arthritis at More Risk for Broken Bones. Nov 5, 2011 487
Studies Show Vectra[TM] DA Multi-Biomarker Test Algorithm More Accurate Than Other Established Disease Activity Measures in Identifying Rheumatoid Arthritis Patients at Risk for Joint Damage Progression. Nov 5, 2011 2112
Data Showed ACTEMRA Monotherapy Significantly Improved Signs and Symptoms of Rheumatoid Arthritis. Nov 5, 2011 1651
Treatment With Enbrel (etanercept) Shows Significant and Sustained Clinical Benefits in Rheumatoid Arthritis (RA) Patients With Moderately Active Disease. Nov 5, 2011 3570
Research and Markets: Rheumatoid Arthritis - Pipeline Review, H2 2011. Nov 4, 2011 434
UCB Reinforces Long-Standing Commitment to Rheumatology at American College of Rheumatology 2011 Annual Scientific Meeting. Nov 4, 2011 985
The Market Share of TNF-alpha Inhibitors for the Treatment of Rheumatoid Arthritis Will Decrease from 75 Percent in 2010 to 53 Percent in 2020. Nov 2, 2011 595
CareFirst BlueCross BlueShield, Cardinal Health Specialty Solutions Launch First Clinical Pathways Program for Rheumatoid Arthritis. Nov 1, 2011 1283
Biogen Idec and Portola Pharmaceuticals Announce Global Collaboration for Oral Syk Inhibitor Program Targeting Autoimmune and Inflammatory Diseases. Oct 27, 2011 1341
Positive Phase 2b Results with Sarilumab in Rheumatoid Arthritis to be Presented as a Late-Breaking Poster at the 2011 American College of Rheumatology Annual Meeting. Oct 27, 2011 1252
Progenra and Tokyo Medical University Form Rheumatoid Arthritis Research Collaboration. Oct 24, 2011 429
Vertex Announces Presentation of New Data for Oral JAK3 Inhibitor VX-509 at Annual Meeting of the American College of Rheumatology. Oct 24, 2011 1565
AcurianHealth Survey Reveals Rheumatoid Arthritis Community Desires New Treatment Options. Clinical report Oct 12, 2011 504
Antares Pharma Granted New U.S. Patent Covering VIBEX[TM] Injector Technology. Oct 4, 2011 1211
Surveyed Rheumatologists Estimate That, in 2014, 24 Percent of Rheumatoid Arthritis Patients Who Receive Tofacitinib Would Be Biologic-Naive and 30 Percent Would Have Been Treated with at Least One TNF-alpha Inhibitor. Oct 3, 2011 661
Crescendo Bioscience Gets $56 Million For Diagnostics. Sep 30, 2011 629
Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018. Sep 28, 2011 774
The Strong Woman's Approach to Managing Rheumatoid Arthritis. Sep 28, 2011 984
REPEAT/The Strong Woman's Approach to Managing Rheumatoid Arthritis. Sep 28, 2011 984
Abbott Japan and Eisai Submit Application in Japan for Additional Indication of Humira(R)(adalimumab), a Fully Human Anti-TNF-alpha Monoclonal Antibody, for Inhibition of Structural Damage of Joints in Rheumatoid Arthritis. Sep 26, 2011 634
Effective herbal treatment for rheumatoid arthritis. Finney-Brown, Tessa Report Sep 22, 2011 402
New 10 Pounds-a-day jab gives hope to millions of arthritis patients. Sep 22, 2011 259
Rheumatoid Arthritis Market Forecast. Industry overview Sep 20, 2011 630
Clinical Trial Recruitment for Autoimmune Diseases Was Highest for Rheumatoid Arthritis During 2000-2009: companiesandmarkets.com. Sep 16, 2011 442
Less plaque progression in TNF inhibitor users. Sullivan, Michele G. Clinical report Sep 15, 2011 866
'The Rheumatoid Arthritis Drugs Market Generated $12.7bn in 2010' Says visiongain Report. Report Sep 8, 2011 1804
Pfizer Announces Detailed Pivotal Data for Investigational Compound Tofacitinib in Rheumatoid Arthritis to be Presented at American College of Rheumatology 2011 Annual Scientific Meeting. Sep 8, 2011 2023
Lack of 'bouncer' protein behind onset of rheumatoid arthritis. Sep 8, 2011 195
Venus Williams reveals mystery illness with no known cure. Sep 1, 2011 282
Subcutaneous biologic approved. Sep 1, 2011 209
Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis and their relationship with extra-articular manifestations/Romatoid artritte anti-siklik sitrulinli peptid antikorlar ve bunlarin ekstra-artikuler bulgular ile iliskisi. Ortancil, Ozgur; Bulmus, Nercivan; Ozdolap, Senay; Kiran, Sibel; Arasli, Mehmet Clinical report Sep 1, 2011 3183
Investigation of glucocorticoid receptor gene Bcl-1 polymorphism in rheumatoid arthritis/romatoid artritte glukokortikoid reseptoru geni Bcl-1 polimorfizminin arastirilmasi. Aydeniz, Ali; Sever, Tugce; Pehlivan, Sacide; Pehlivan, Mustafa; Altindag, Ozlem; Budeyri, Selin; Gu Report Sep 1, 2011 2829
Serum levels of anti-citrullinated protein antibody (ACPA) and tweak in patients with rheumatoid arthritis: association with disease activity and treatment modalities / romatoid artritli hastalarda serum TWEAK ve anti-sitrulinlenmis protein antikor (ACPA) seviyeleri: tedavi yontemleri ve hastalik aktivitesiyle iliskisi. Karkucak, Murat; Capkin, Erhan; Cakirbay, Hasim; Alver, Ayse; Cansu, Aysegul; Demirok, Duygu; Tosun, Report Sep 1, 2011 3667
Fear of falling, fall risk and disability in patients with rheumatoid arthritis / romatoid artritli hastalarda dusme korkusu, dusme riski ve disabilite. Cakit, Burcu Duyur; Nacir, Baris; Erdem, Hatice Rana; Karagoz, Aynur; Saracoglu, Meryem Clinical report Sep 1, 2011 5905
Blocking TNF-[alpha] in complex regional pain syndrome type I: A case of reflex sympathetic dystrophy resolved with etanercept in a patient with ankylosing spondylitis / kompleks bolgesel agri sendromu tip i'de tnf-[alpha] blokaji: Ankilozan spondilitli bir hastada gelisen ve etanersept ile iyilesen bir refleks sempatik distrofi olgusu. Ozgul, Ahmet; Vural, Dilek; Taskaynatan, Mehmet Ali Report Sep 1, 2011 2395
Pleuropericarditis associated with sulphasalazine in a case of rheumatoid arthritis: a drug-induced lupus-like syndrome / romatoid artritli bir olguda sulfasalazinle iliskili ploroperikardit: ilac kaynakli lupus benzeri sendrom. Hiz, Ozcan; Gulcu, Elif; Ozkan, Yasemin; Tekeoglu, Ibrahim; Aladag, Nesim Report Sep 1, 2011 2427
Coexistence of Behcet's disease and ankylosing spondylitis: behcet hastaligi ve Ankilozan spondilit birlikteligi. Celik, Canan; Ucan, Halil; Uckun, Asli Caliskan; Alemdaroglu, Ebru Sep 1, 2011 1272
Defective gene behind rheumatoid arthritis identified. Aug 17, 2011 257
Arthritis sufferers at increased risk of dying due to cardiovascular disease. Aug 15, 2011 236
Genetic clue behind rheumatoid arthritis, autoimmune disorders identified. Disease/Disorder overview Aug 15, 2011 212
The effects of rose hip (Rosa canina) on plasma antioxidative activity and C-reactive protein in patients with rheumatoid arthritis and normal controls: a prospective cohort study. Kirkeskov, Bente; Christensen, Robin; Bugel, Susanne; Bliddal, Henning; Danneskiold-Samsoe, Bente; P Report Aug 15, 2011 5878
Over 40 Percent of U.S. Rheumatoid Arthritis Patients Who Have Never Taken a Biologic Drug Have Discussed the Possibility of Starting These Treatments with Their Physician According to a New Study by BioTrends Research Group. Aug 11, 2011 496
Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule 'Revamilast'. Aug 10, 2011 1008
Arthritis Patient Helped Create Innovative Knee Implant That Restored His Active Lifestyle. Aug 8, 2011 691
Antares Pharma Announces Positive Study Results with VIBEX[TM] MTX in Rheumatoid Arthritis Patients. Aug 4, 2011 1173
AB Science announces recruitment of first patient in phase 2B/3 study of masitinib in rheumatoid arthritis. Clinical report Aug 3, 2011 1017
Femta Pharmaceuticals Announces IND Filing of FM101, a Novel Monoclonal Antibody Targeting IL-6 with Potent Anti-Inflammatory Activity. Aug 1, 2011 569
Post-MI cardioprotection missed in RA patients. Freeman, Sara Aug 1, 2011 566

Terms of use | Copyright © 2013 Farlex, Inc. | Feedback | For webmasters | Submit articles